ARCHIVES

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

This article is from The Cancer Letter archive.

Vol. 15 No. 16 | April 21, 1989

Download PDF Visit The Full Archive

Related Articles

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote

July 2, 1999

DePinho’s Letter to CPRIT’s Gimson, And Gimson’s Response

June 1, 2012

Report Urges Better Working Conditions For Postdocs.

October 6, 2000

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

September 15, 2006

Zytiga Plus Prednisone Shows Improvement in PFS and OS Over Prednisone Alone

June 29, 2012